ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESI....FIRO..CY..TRBGCZEEHUPLSK....................................*JBDM Ver 0.1.59 (03 Mar 2017) - 2999001/01631264CORRECTED NEW EUROPEAN PATENT SPECIFICATIONB8B220170524W173deBibliographieenBibliographyfrBibliographieEP04776195.220040602200512082008040420170308enenen475010 P20030602US513074 P20031021US2017052420172120060308200610200907292009312009013020091029BG20140602CY20140602CZ20090729DK20090729EE20090729FI20140602LU20140630MC20090729RO20090729SE20090729SI20090729SK2017030820171020170524201721A61K 9/50 20060101AFI20050316BHEP A61K 9/16 20060101ALI20050316BHEP A61K 9/02 20060101ALI20050316BHEP A61K 9/08 20060101ALI20050316BHEP A61K 39/12 20060101ALI20050316BHEP deIMMUNOGENE, AUF MIKROPARTIKEL BASIERENDE ZUSAMMENSETZUNGEN, DIE AUS EINEM ADSORBIERTEN TOXOID UND EINEM POLYSACCHARID ENTHALTENDEN ANTIGEN BESTEHENenIMMUNOGENIC COMPOSITIONS BASED ON MICROPARTICLES COMPRISING ADSORBED TOXOID AND A POLYSACCHARIDE-CONTAINING ANTIGENfrCOMPOSITIONS IMMUNOGENES BASEES SUR DES MICROPARTICULES BIODEGRADABLES COMPRENANT DES ANATOXINES DIPHTHERIQUES ET TETANIQUESWO-A-02/26209US-A- 5 981 719US-A- 6 007 845US-A1- 2002 136 776PEYRE-M. SESARDIC-D. MERKLE-H-P, GANDER-B, JOHANSEN-P.: "Divalent Microsphere Vaccines Are Protective Against Tetanus and Diphtheria" PROCEED. IN'L. SYMP. CONTROL. REL. BIOACT. MATER., vol. 28, 2001, pages 1077-1078, XP009042702I. JABBAL-GILL ET AL.: 'Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines' VACCINE vol. 18, 2000, pages 238 - 35009075251.0217972920090608O'HAGAN, DerekNovartis Vaccines and Diagnostics, Inc. 4560 Horton StreetEmeryville, CA 94608USSINGH, ManmohanNovartis Vaccines and Diagnostics, Inc. 4560 Horton StreetEmeryville, CA 94608USKAZZAZ, JinaNovartis Vaccines and Diagnostics, Inc. 4560 Horton StreetEmeryville, CA 94608USGlaxoSmithKline Biologicals SA100750201P042546EPRue de l'Institut 891330 RixensartBEChapman, Desmond Market al101356628Carpmaels & Ransford LLP One Southampton RowLondon WC1B 5HAGB01201004294GlaxoSmithKline Biologicals s.a.10070207089 rue de l'Institut1330 RixensartBEDalton, Marcus Jonathan Williamet al101447594GlaxoSmithKline Global Patents (CN925.1) 980 Great West RoadBrentford, Middlesex TW8 9GSGBATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEITLILUMCNLPLPTROSESISKTRUS200401712520040602enWO20050209642005031020051020060308200610